🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This phase II trial tests how well duvelisib works as treatment that is giv...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT07293403
Therapy related acute myeloid leukemia and myelodysplasia (t-MN) is a poten...
Status
Recruiting
Location
Istituto Europeo di Oncologia
Start Date
2020-10-02
Trial ID
NCT06785077
Treatments Being Tested
This phase II trial tests the effect of total marrow and lymphoid irradiati...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-05
Trial ID
NCT07582172
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow and...
Status
Recruiting
Location
Stony Brook Cancer Center
Start Date
2024-05-17
Trial ID
NCT06297551
Treatments Being Tested
It is a translational research study with mechanistical objectives and incl...
Status
Unknown
Location
Immunopathologie Clinique - Hôpital Saint Louis - AP HP
Start Date
2020-09-07
Trial ID
NCT04003220
Treatments Being Tested
This initial cohort of this phase II trial studied the outcomes of using a ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-02-09
Trial ID
NCT04370301
Treatments Being Tested
This study is a clinical study aiming at establishing immunological assays ...
Status
Completed
Location
Peter MacCallum Cancer Center
Start Date
2013-10
Trial ID
NCT02016833
Treatments Being Tested
The goal of this observational study is to characterize the diagnostic and ...
Status
Recruiting
Location
Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Start Date
2019-06-01
Trial ID
NCT05931718
RATIONALE: Radiolabeled monoclonal antibodies, such as yttrium Y 90 ibritum...
Status
Completed
Location
Multiple Locations
Start Date
2000-05-16
Trial ID
NCT00562978
Treatments Being Tested